A study showing that Novo Nordisk's Wegovy has the ability to reduce the risk of serious heart problems in some patients by 20% was published in the New England Journal of Medicine.
The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients.
Wegovy cuts heart risks by 20% in large trial medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients.
Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds usf.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usf.edu Daily Mail and Mail on Sunday newspapers.